Created in 2004 (Switzerland), XICLAV own 2951 sister brands and 17477 competing brands. The XICLAV brand is owned by NOVARTIS N, a company listed in Zurich. The ISIN, the company's International Securities Identification Number, is CH0012005267. The sector of XICLAV is Drug Manufacturers.
Investment simulator :
Portfolio valuation
NOVARTIS N
(XICLAV)
over 5 years*
CHF 100.18